Long-term simulation of lead concentrations in agricultural soils in relation to human adverse health effects.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
07 2020
Historique:
received: 17 03 2020
accepted: 22 04 2020
pubmed: 7 5 2020
medline: 13 7 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

Lead (Pb) exposure of consumers and the environment has been reduced over the past decades. Despite all measures taken, immission of Pb onto agricultural soils still occurs, with fertilizer application, lead shot from hunting activities, and Pb from air deposition representing major sources. Little is known about the intermediate and long-term consequences of these emissions. To gain more insight, we established a mathematical model that considers input from fertilizer, ammunition, deposition from air, uptake of Pb by crops, and wash-out to simulate the resulting Pb concentrations in soil over extended periods. In a further step, human oral exposure by crop-based food was simulated and blood concentrations were derived to estimate the margin of exposure to Pb-induced toxic effects. Simulating current farming scenarios, a new equilibrium concentration of Pb in soil would be established after several centuries. Developmental neurotoxicity represents the most critical toxicological effect of Pb for humans. According to our model, a Pb concentration of ~ 5 mg/kg in agricultural soil leads to an intake of approximately 10 µg Pb per person per day by the consumption of agricultural products, the dose corresponding to the tolerable daily intake (TDI). Therefore, 5 mg Pb/kg represents a critical concentration in soil that should not be exceeded. Starting with a soil concentration of 0.1 mg/kg, the current control level for crop fields, our simulation predicts periods of ~ 50 and ~ 175 years for two Pb immission scenarios for mass of Pb per area and year [scenario 1: ~ 400 g Pb/(ha × a); scenario 2: ~ 175 g Pb/(ha × a)], until the critical concentration of ~ 5 mg/kg Pb in soil would be reached. The two scenarios, which differ in their Pb input via fertilizer, represent relatively high but not unrealistic Pb immissions. From these scenarios, we calculated that the annual deposition of Pb onto soil should remain below ~ 100 g/(ha × a) in order not to exceed the critical soil level of 5 mg/kg. We propose as efficient measures to reduce Pb input into agricultural soil to lower the Pb content of compost and to use alternatives to Pb ammunition for hunting.

Identifiants

pubmed: 32372210
doi: 10.1007/s00204-020-02762-x
pii: 10.1007/s00204-020-02762-x
pmc: PMC7367917
doi:

Substances chimiques

Fertilizers 0
Soil 0
Lead 2P299V784P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2319-2329

Références

IARC Monogr Eval Carcinog Risks Hum. 2006;87:1-471
pubmed: 17191367
Crit Rev Toxicol. 2011 Apr;41(4):263-91
pubmed: 21438738
Environ Sci Pollut Res Int. 2017 Jul;24(19):16371-16382
pubmed: 28550630
Arch Toxicol. 2008 Apr;82(4):211-36
pubmed: 18322675
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Oct;52(10):977-82
pubmed: 19802622
Ecotoxicol Environ Saf. 2018 Jan;147:1035-1045
pubmed: 29976006
Environ Int. 2018 Dec;121(Pt 1):85-101
pubmed: 30179767
J Environ Sci (China). 2006;18(6):1094-100
pubmed: 17294948
J Environ Qual. 2014 Mar;43(2):475-87
pubmed: 25602649
Environ Res. 1995 Feb;68(2):82-90
pubmed: 7601076
Environ Int. 2016 Mar;88:299-309
pubmed: 26851498
Environ Sci Technol. 2013 Jan 2;47(1):563-7
pubmed: 23189972
Cancer Res. 1995 Nov 15;55(22):5265-71
pubmed: 7585586
Arch Toxicol. 2015 Dec;89(12):2219-27
pubmed: 26586021
JAMA. 1994 Jul 27;272(4):284-91
pubmed: 8028141
Environ Pollut. 1996;94(2):181-8
pubmed: 15093504
Arch Toxicol. 2014 Dec;88(12):2191-211
pubmed: 25326817
PLoS One. 2010 Apr 26;5(4):e10315
pubmed: 20436670
Environ Pollut. 2007 Sep;149(2):149-57
pubmed: 17360092
Environ Pollut. 2006 Nov;144(1):127-35
pubmed: 16516364
Ecotoxicol Environ Saf. 2010 May;73(4):632-41
pubmed: 20163857
Risk Anal. 2013 Mar;33(3):450-61
pubmed: 22924487
Toxicology. 2006 Mar 15;220(2-3):232-9
pubmed: 16555380
Environ Sci Pollut Res Int. 2011 Jul;18(6):918-39
pubmed: 21274642

Auteurs

Thomas Schupp (T)

Faculty of Chemical Engineering, Muenster University of Applied Science, Stegerwaldstrasse 39, 48565, Steinfurt, Germany. thomas.schupp@fh-muenster.de.

Georg Damm (G)

Department für Hepatobiliäre Chirurgie und Viszerale Transplantation, Universität Leipzig, Liebigstrasse 20, 04103, Leipzig, Germany.

Heidi Foth (H)

Institut für Umwelttoxikologie, Martin Luther Universität Halle, Franzosenweg 1, 06108, Halle (Saale), Germany.

Alexius Freyberger (A)

Pathology and Clinical Pathology, Bayer Aktiengesellschaft, Aprather Weg 18a, 421113, Wuppertal, Germany.

Thomas Gebel (T)

Federal Institute for Occupational Safety and Health, Friedrich-Henkel-Weg 1-25, 44149, Dortmund, Germany.

Ursula Gundert-Remy (U)

Charité, Institute of Clinical Pharmacology and Toxicology, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.

Jan G Hengstler (JG)

Leibniz-Institut für Arbeitsforschung an der TU Dortmund (IfADo), Ardeystrasse 67, 44139, Dortmund, Germany.

Aswin Mangerich (A)

Molecular Toxicology Group, Department of Biology, University of Konstanz, Box 628, 78457, Konstanz, Germany.

Falko Partosch (F)

Institut für Arbeitsmedizin, Universitätsmedizin Göttingen, Waldweg 37b, 37073, Göttingen, Germany.

Claudia Röhl (C)

Department of Environmental Health Protection, Schleswig-Holstein State Agency for Social Services, 24105, Kiel, Germany.

Klaus-Michael Wollin (KM)

Niedersächsisches Landesgesundheitsamt, 30449, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH